Benjamin F. Edwards & Company’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
TCM
BBA
Benjamin F. Edwards & Company's BLUE Position: Q2 2022 in Review
Benjamin F. Edwards & Company sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 7 shares — an estimated $1K sold.
Benjamin F. Edwards & Company first reported a position in BLUE in Q1 2015 and held it in 23 quarters. The position peaked at $164K in Q3 2020. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.
- Benjamin F. Edwards & Company reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
- Benjamin F. Edwards & Company sold 7 bluebird bio shares in Q2 2022, an estimated $1K.
- Benjamin F. Edwards & Company first reported a position in bluebird bio in Q1 2015 and held it in 23 quarters.
- Benjamin F. Edwards & Company's bluebird bio position peaked at $164K in Q3 2020.
- 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.
Based on Benjamin F. Edwards & Company's 13F filing for Q2 2022, filed 12 Aug 2022.